Both classifications exclude JMML from the category of overlap neoplasms, since JMML is a pediatric-onset entity with germline predisposition, typically characterized by the presence of germline PTPN11, CBL, and NF1 mutations and by predominantly myeloproliferative features. Here, NF1 is linked to neoplasm.